Tamoxifen as an effective neuroprotectant against early brain injury and learning deficits induced by subarachnoid hemorrhage: Possible involvement of inflammatory signaling

Journal of Neuroinflammation

Volumn 10, Issue , 2013, Pages

  Sun, Xuebo ^a   Ji, Chengyuan ^a   Hu, Tong ^a   Wang, Zhong ^a   Chen, Gang ^a,b  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

Early brain injury; Inflammation; Learning deficits; Subarachnoid hemorrhage; Tamoxifen

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; TAMOXIFEN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; BRAIN DAMAGE; BRAIN EDEMA; CONTROLLED STUDY; DNA BINDING; LEARNING DISORDER; MALE; MORRIS WATER MAZE TEST; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; RAT; SPRAGUE DAWLEY RAT; SUBARACHNOID HEMORRHAGE; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BRAIN INJURIES; DISEASE MODELS, ANIMAL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; INFLAMMATION; MALE; MAZE LEARNING; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SUBARACHNOID HEMORRHAGE; TAMOXIFEN;

EID: 84890976507     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-10-157     Document Type: Article

References (24)

1. Bian LH, Liu YF, Nichols LT, Wang CX, Wang YL, Liu GF, Wang WJ, Zhao XQ. Epidemiology of subarachnoid hemorrhage, patterns of management, and outcomes in China: a hospital-based multicenter prospective study. CNS Neurosci Ther 2012, 18:895-902. 10.1111/cns.12001, 22966850.
2. Sabri M, Lass E, Macdonald RL. Early brain injury: a common mechanism in subarachnoid hemorrhage and global cerebral ischemia. Stroke Res Treat 2013, 2013:394036. 3603523, 23533958.
3. Caner B, Hou J, Altay O, Fuj M, Zhang JH. Transition of research focus from vasospasm to early brain injury after subarachnoid hemorrhage. J Neurochem 2012, 123(Suppl 2):12-21.
4. Sehba FA, Hou J, Pluta RM, Zhang JH. The importance of early brain injury after subarachnoid hemorrhage. Prog Neurobiol 2012, 97:14-37. 10.1016/j.pneurobio.2012.02.003, 3327829, 22414893.
5. Al-Khindi T, Macdonald RL, Schweizer TA. Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage. Stroke 2010, 41:e519-e536. 10.1161/STROKEAHA.110.581975, 20595669.
6. Kunath F, Keck B, Antes G, Wullich B, Meerpohl JJ. Tamoxifen for the management of breast events induced by non-steroidal antiandrogens in patients with prostate cancer: a systematic review. BMC Med 2012, 10:96. 10.1186/1741-7015-10-96, 3464149, 22925442.
7. Tian DS, Liu JL, Xie MJ, Zhan Y, Qu WS, Yu ZY, Tang ZP, Pan DJ, Wang W. Tamoxifen attenuates inflammatory-mediated damage and improves functional outcome after spinal cord injury in rats. J Neurochem 2009, 109:1658-1667. 10.1111/j.1471-4159.2009.06077.x, 19457130.
8. Xie Q, Guan J, Wu G, Xi G, Keep RF, Hua Y. Tamoxifen treatment for intracerebral hemorrhage. Acta Neurochir Suppl 2011, 111:271-275. 10.1007/978-3-7091-0693-8_45, 21725767.
9. Osuka K, Feustel PJ, Mongin AA, Tranmer BI, Kimelberq HK. Tamoxifen inhibits nitrotyrosine formation after reversible middle cerebral artery occlusion in the rat. J Neurochem 2001, 76:1842-1850. 10.1046/j.1471-4159.2001.00198.x, 11259502.
10. Feng Y, Fratkins JD, LeBlanc MH. Treatment with tamoxifen reduces hypoxic-ischemic brain injury in neonatal rats. Eur J Pharmacol 2004, 484:65-74. 10.1016/j.ejphar.2003.10.048, 14729383.
11. Tapia-Gonzalez S, Carrero P, Pernia O, Garcia-Segura LM, Diz-Chaves Y. Selective oestrogen receptor (ER) modulators reduce microglia reactivity in vivo after peripheral inflammation: potential role of microglial ERs. J Endocrinol 2008, 198:219-230. 10.1677/JOE-07-0294, 18460549.
12. Suuronen T, Nuutinen T, Huuskonen J, Ojala J, Thornell A, Salminen A. Anti-inflammatory effect of selective estrogen receptor modulators (SERMs) in microglial cells. Inflamm Res 2005, 54:194-203. 10.1007/s00011-005-1343-z, 15953991.
13. Wang Z, Ma C, Meng CJ, Zhu GQ, Sun XB, Huo L, Zhang J, Liu HX, He WC, Shen XM, Shu Z, Chen G. Melatonin activates the Nrf2-ARE pathway when it protects against early brain injury in a subarachnoid hemorrhage model. J Pineal Res 2012, 53:129-137. 10.1111/j.1600-079X.2012.00978.x, 22304528.
14. Roof RL, Duvdevani R, Heyburn JW, Stein DG. Progesterone rapidly decreases brain edema: treatment delayed up to 24 hours is still effective. Exp Neurol 1996, 138:246-251. 10.1006/exnr.1996.0063, 8620923.
15. Yamaguchi M, Zhou C, Nanda A, Zhang JH. Ras protein contributes to cerebral vasospasm in a canine double hemorrhage model. Stroke 2004, 35:1750-1755. 10.1161/01.STR.0000129898.68350.9f, 15143294.
16. Chen G, Shi JX, Hang CH, Xie W, Liu J, Liu X. Inhibitory effect on cerebral inflammatory agents that accompany traumatic brain injury in a rat model: a potential neuroprotective mechanism of recombinant human erythropoietin (rhEPO). Neurosci Lett 2007, 425:177-182. 10.1016/j.neulet.2007.08.022, 17825990.
17. Jeon H, Ai J, Sabri M, Tariq A, Macdonald RL. Learning deficits after experimental subarachnoid hemorrhage in rats. Neuroscience 2010, 169:1805-1814. 10.1016/j.neuroscience.2010.06.039, 20600651.
18. Chuang SE, Yeh PY, Lu YS, Lai GM, Liao CM, Gao M, Cheng AL. Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB (NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells. Biochem Pharmacol 2002, 63:1709-1716. 10.1016/S0006-2952(02)00931-0, 12007574.
19. Liu JL, Tian DS, Li ZW, Qu WS, Zhan Y, Xie MJ, Yu ZY, Wang W, Wu G. Tamoxifen alleviates irradiation-induced brain injury by attenuating microglial inflammatory response in vitro and in vivo. Brain Res 2010, 1316:101-111.
20. Provencio JJ. Inflammation in subarachnoid hemorrhage and delayed deterioration associated with vasospasm: a review. Acta Neurochir Suppl 2013, 115:233-238. 3597075, 22890674.
21. Wang Z, Zuo G, Shi XY, Zhang J, Fang Q, Chen G. Progesterone administration modulates cortical TLR4/NF-κB signaling pathway after subarachnoid hemorrhage in male rats. Mediators Inflamm 2011, 2011:848309. 3051156, 21403869.
22. Fang Q, Chen G, Zhu W, Dong W, Wang Z. Influence of melatonin on cerebrovascular proinflammatory mediators expression and oxidative stress following subarachnoid hemorrhage in rabbits. Mediators Inflamm 2009, 2009:426346. 2821769, 20169093.
23. Arevalo MA, Diz-Chaves Y, Santos-Galindo M, Bellini MJ, Garcia-Segura LM. Selective oestrogen receptor modulators decrease the inflammatory response of glial cells. J Neuroendocrinol 2012, 24:183-190. 10.1111/j.1365-2826.2011.02156.x, 21564348.
24. Cerciat M, Unkila M, Garcia-Segura LM, Arevalo MA. Selective estrogen receptor modulators decrease the production of interleukin-6 and interferon-gamma-inducible protein-10 by astrocytes exposed to inflammatory challenge in vitro. Glia 2010, 58:93-102. 10.1002/glia.20904, 19533603.